Enovis (ENOV) EBT Growth (5y) (2015 - 2026)
Enovis (ENOV) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -55.33% |
| Dec 31, 2025 | -28.72% |
| Oct 3, 2025 | -77.44% |
| Jul 4, 2025 | 5.03% |
| Apr 4, 2025 | -35.73% |
| Dec 31, 2024 | -67.99% |
| Sep 27, 2024 | -81.37% |
| Jun 28, 2024 | -39.36% |
| Mar 29, 2024 | -32.37% |
| Dec 31, 2023 | -7.29% |
| Sep 29, 2023 | -25.31% |
| Jun 30, 2023 | -20.31% |
| Mar 31, 2023 | -22.79% |
| Dec 31, 2022 | 54.30% |
| Sep 30, 2022 | -26.46% |
| Jul 1, 2022 | 13.58% |
| Apr 1, 2022 | -22.33% |
| Dec 31, 2021 | -66.00% |
| Oct 1, 2021 | -19.03% |
| Jul 2, 2021 | -22.10% |